In vitro antibacterial activity of BMY-28142, a new extended-spectrum cephalosporin.

The in vitro activity of BMY-28142 was compared with that of cefotaxime, ceftazidime, moxalactam, and imipenem against 639 clinical isolates and a number of in vitro-selected resistant mutants. BMY-28142 was the most potent compound against the members of the family Enterobacteriaceae with a MIC for...

Ausführliche Beschreibung

Bibliografische Detailangaben

Veröffentlicht in:	Antimicrob Agents Chemother
Hauptverfasser:	Vuye, A, Pijck, J
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	American Society for Microbiology (ASM) 1985
Schlagworte:	Research Article
Online-Zugang:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC180098/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3859244/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.27.4.574
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!